U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

 

FDA
Press Announcements
November 23, 2021 – Coronavirus (COVID-19) Update: November 23, 2021

 

 

Vaccines and Related Biological Products Advisory Committee– FDA
https://www.fda.gov/advisory-committees/blood-vaccines-and-other-biologics/vaccines-and-related-biological-products-advisory-committee
No meetings on calendar

 

 

::::::

 

White House [U.S.]
Briefing Room – Selected Major COVID Announcements
A Proclamation on Suspension of Entry as Immigrants and Nonimmigrants of Certain Additional Persons Who Pose a Risk of Transmitting Coronavirus Disease 2019
November 26, 2021 • Presidential Actions

Statement by President Joe Biden on the Omicron COVID-⁠19 Variant
November 26, 2021 • Statements and Releases

Press Briefing by White House COVID-⁠19 Response Team and Public Health Officials
November 22, 2021 • Press Briefings

 

 

U.S. Department of State
https://www.state.gov/coronavirus/releases/
Media Notes
Remarks
Secretary Antony J. Blinken at the Institute Pasteur of Dakar
Antony J. Blinken November 20, 2021
“…Our ambition is really to impact COVID-19 pandemic by delivering COVID vaccine in Africa for Africa before this pandemic ends.  We also want to establish large capacity for future pandemics, epidemic, and also for routine immunization.  We really looking for partnering with company in pandemic preparedness space in the U.S. and elsewhere, and we are really looking forward to establishing cell culture and RNA messenger capacity for many vaccine important for us, the end goal being to support Africa vaccine autonomy in collaboration with as a regional – that African Union is working on….”